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TNF-like weak inducer of apoptosis (TWEAK), a member of the tumor necrosis factor (TNF) family, is a
multifunctional cytokine that regulate cellular proliferation, angiogenesis, inﬂammation, and apoptosis. In this
study, we investigated the effect of TWEAK on human keratinocytes. Primary cultured normal human keratinocytes
constitutively expressed a TWEAK receptor, ﬁbroblast growth factor-inducible 14 (Fn14), and produced regulated
on activation, normal T expressed and secreted (RANTES) upon TWEAK stimulation in a concentration-dependent
manner. The TWEAK-induced RANTES production was abrogated by anti-Fn14 antibody, and synergistically
augmented by simultaneous stimulation with transforming growth factor-b. In addition, human keratinocytes
differentiated in vitro with high Ca2þ -containing medium showed enhanced production of RANTES upon TWEAK
stimulation. Furthermore, TWEAK induced rapid phosphorylation of IjB-a in human keratinocytes. Collectively,
TWEAK acts on human keratinocytes as an inducer of RANTES via Fn14. Because RANTES has been implicated in
inﬂammation, TWEAK/Fn14 interaction in human keratinocytes may be involved in the pathophysiology of
inﬂammatory skin disorders.
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TNF-like weak inducer of apoptosis (TWEAK) was first
identified as a new member of the tumor necrosis factor
(TNF) superfamily which induced cell death in some tumor
cell lines (Chicheportiche et al, 1997; Schneider et al, 1999;
Nakayama et al, 2000). The human TWEAK gene is
expressed in many different cell types and encodes a
 30 kDa type II transmembrane protein that can be
cleaved to generate a  18 kDa soluble factor with
biological activity. Recently, Wiley et al (2001) have
identified fibroblast growth factor-inducible 14 (Fn14) as a
TWEAK receptor with physiological affinity. Fn14 is a type I
transmembrane protein composed of only one cysteine-rich
domain in the extracellular region and a short cytoplasmic
region containing a TNF receptor-associated factor (TRAF)-
binding motif. Saitoh et al (2003) recently reported that
TWEAK stimulates two nuclear factor-kB (NF-kB) signaling
pathways: IkB-a phosphorylation and p100 processing via
TRAF molecules. These findings have suggested that
TWEAK has other biological functions associated with NF-
kB activation than regulating cell death.
Recent evidence indeed reveals that TWEAK is a
multifunctional cytokine that regulated cellular proliferation,
angiogenesis, and inflammation (Wiley and Winkles, 2003).
Lynch et al (1999) reported that TWEAK induced pro-
liferation of endothelial cells and angiogenesis. We also
reported that TWEAK upregulated cell surface expression of
adhesion molecules and induced secretion of chemokines
such as interleukin (IL)-8 and monocyte chemotactic protein
(MCP)-1 in human umbilical vein endothelial cells (HUVEC)
(Harada et al, 2002). Furthermore, TWEAK induced several
cytokines/chemokines such as IL-8, inducible protein (IP)-
10, and regulated on activation, normal T expressed and
secreted (RANTES) in human dermal fibroblasts and
synoviocytes (Chicheportiche et al, 2002). Furthermore,
TWEAK induced several cytokines/chemokines such as
IL¼8, IP¼10, and RANTES in human dermal fibroblasts
and synoriocytes (Chicheportiche et al, 2002).
In this study, we investigated Fn14 expression on
human keratinocytes and examined the effect of TWEAK
on chemokine production by human keratinocytes. We
found that TWEAK stimulated human keratinocytes to
produce a CCL chemokine, RANTES, via Fn14. Thus,
TWEAK acts on human keratinocytes as an inducer of
RANTES. Because RANTES is a potent chemoattractant
for leukocytes and has been associated with a wide
range of inflammatory disorders (Homey and Zlotnik,
1999; Zlotnik and Yoshie, 2000; Appay and Rowland-Jones,
2001), TWEAK/Fn14 interaction in human keratinocytes
may be involved in pathophysiology of certain inflammatory
skin diseases.
Abbreviations: Fn14, fibroblast growth factor-inducible 14; IFN-g,
interferon-g; IL, interleukin; NF-kB, nuclear factor-kB; RANTES,
regulated on activation, normal T expressed and secreted; TGF-b,
transforming growth factor-b; TNF, tumor necrosis factor; TWEAK,
TNF-like weak inducer of apoptosis
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Results
Human keratinocytes constitutively express Fn14 To
determine whether TWEAK may act on keratinocytes, we
first examined the expression of Fn14 on cultured human
keratinocytes. Flourescence activated cell sorting (FACS)-
analysis using anti-Fn14 mAb showed that human kerati-
nocytes expressed a high level of Fn14 on the cell surface,
which was not affected by the presence or absence of EGF
in the culture medium (Fig 1). Since Fn14 expression in
endothelial cells and fibroblasts has been reported to be
regulated by several growth factors and cytokines (Nakaya-
ma et al, 2000; Donohue et al, 2003; Wiley and Winkles,
2003), we next determined whether the Fn14 expression on
human keratinocytes was regulated by certain cytokines. As
shown in Fig 1, we found that the expression of Fn14 on
keratinocytes was not affected by IFN-g or TGF-b1.
TWEAK induces RANTES production by human kerati-
nocytes Since cultured human keratinocytes constitutively
expressed Fn14, we then investigated whether TWEAK
could stimulate human keratinocytes through Fn14. Pre-
vious studies have shown that human keratinocytes could
produce several chemokines that were associated with
inflammatory skin diseases (Ying et al, 1995; Giustizieri et al,
2001; Horikawa et al, 2002). We thus examined the effect of
recombinant TWEAK on IL-8, MCP-1, thymus and activa-
tion-regulated cytokine (TARC), Eotaxin, and RANTES
production by human keratinocytes. As shown in Fig 2,
TWEAK induced RANTES production in a concentration-
dependent manner, which was almost completely inhibited
by blocking the TWEAK/Fn14 interaction with anti-Fn14
mAb (Fig 2). In contrast, IL-8, MCP-1, TARC, and Eotaxin
were not significantly produced in the presence or absence
of TWEAK (data not shown). These findings indicated
that TWEAK stimulated human keratinocytes to produce
RANTES via Fn14.
TGF-b synergistically augments TWEAK-induced
RANTES production by human keratinocytes TGF-b
has been implicated in the regulation of inflammation (Wahl,
1992) and is constitutively expressed in the human
epidermis (Quan et al, 2002). We were thus interested in
examining the effect of TGF-b on TWEAK-induced RANTES
production by human keratinocytes. TGF-b1 alone mod-
estly induced RANTES production by human keratinocytes
(Fig 3). Notably, TGF-b1 showed a synergistic effect on the
TWEAK-induced RANES production by human keratino-
cytes in a concentration-dependent manner (Fig 3). These
findings indicated that TGF-b and TWEAK acted synergis-
tically for RANTES production by human keratinocytes.
Differentiated human keratinocytes produce more
RANTES upon TWEAK and TGF-b stimulation We next
examined the effects of TWEAK and/or TGF-b1 on more
differentiated keratinocytes. The human keratinocytes cul-
tured in the presence of 1.2 mM Ca2þ for 2 d ceased
proliferation, stratified and cornified as previously described
(Stanley and Yuspa, 1983). As compared with the undiffer-
entiated keratinocytes that were maintained in the culture
medium containing 0.05 mM Ca2þ , the differentiated
keratinocytes produced a comparable amount of RANTES
in response to TWEAK alone but more RANTES in response
to TGF-b1 alone (Fig 4). Moreover, the differentiated
keratinocytes produced significantly increased amounts of
RANTES in response to the combination of TWEAK and
TGF-b1 (Fig 4).
Phosphorylation of IjB-a in TWEAK-stimulated human
keratinocytes To explore the mechanisms by which
TWEAK stimulated human keratinocytes, we investigated
IkB-a phosphorylation in TWEAK-stimulated human kerati-
nocytes. Saitoh et al (2003) showed that TWEAK induced
phosphorylation of IkB-a, resulting in NF-kB activation in
fibroblasts . As shown in Fig 5A, we found that TWEAK
induced phosphorylation of IkB-a at 10 min after the
stimulation in cultured human keratinocytes. Moreover,
TWEAK and TGF-b1 showed an additive increase of
Figure 1
Cell surface expression of Fn14 on human keratinocytes. Cultured
human keratinocytes were untreated or treated with 10 ng per mL of
TGF-b1 or 10 ng per mL of IFN-g for 24 h in EGF() or EGF(þ ) medium.
Then, cells were stained with biotinylated anti-human Fn14 mAb (open
histograms) or control Ig (filled histograms), followed by PE-labeled
avidin, and then analyzed by flow cytometry. Representative of three
repeated experiments with similar results were shown.
Figure2
TWEAK induces RANTES production by human keratinocytes via
Fn14. Cultured human keratinocytes were stimulated with the indicated
doses of recombinant human TWEAK in the presence or absence of
anti-Fn14 blocking mAb (5 mg per mL). for 48 h. Then, human RANTES
concentration in the culture supernatants was measured by ELISA.
Data are indicated as the mean  SD of triplicate samples. po0.05,
significantly different from the mean value of the corresponding control
response. Similar results were obtained in three repeated experiments.
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phosphorylation of IkB-a (Fig 5B), which might be at least in
part responsible for their synergistic action on the RANTES
production.
Discussion
In this study, we demonstrated that cultured human
keratinocytes expressed Fn14, which was responsible for
TWEAK-induced RANTES production (Figs 1 and 2).
TWEAK and TGF-b1 synergized to induce RANTES produc-
tion by keratinocytes, and differentiated keratinocytes
produced more RANTES in response to TWEAK and TGF-
b1 (Figs 3 and 4). Because RANTES is a pro-inflammatory
chemokine mediating the trafficking and homing of T cells,
monocytes, eosinophils, natural killer cells, and mast cells
(Homey and Zlotnik, 1999; Zlotnik and Yoshie, 2000; Appay
and Rowland-Jones, 2001), these results suggest that
TWEAK/Fn14 interaction in human keratinocytes may be
involved in the pathogenesis of inflammatory skin disorders
through RANTES production.
Cultured human keratinocytes constitutively expressed
Fn14 on the cell surface (Fig 1). Because some growth
factors or mitogens, including fibroblast growth factor (FGF)-
and phorbol myristate acetate (PMA), regulated Fn14
expression in endothelial cells and fibroblasts (Meighan-
Mantha et al, 1999; Donohue et al, 2003), we examined the
influence of EGF in the keratinocyte culture and found that
the Fn14 expression on human keratinocytes was not
changed. We also found that IFN-g or TGF-b1 did not affect
the cell surface Fn14 expression on cultured human
keratinocytes. Thus, it appeared that Fn14 expression on
human keratinocytes was relatively stable as compared
with endothelial cells and fibroblasts, although other growth
factors or cytokines should be tested for possible regulation
of Fn14 in human keratinocytes.
TWEAK induced RANTES, but not IL-8, MCP-1, TARC,
and Eotaxin production in human keratinocytes (Fig 2 and
Figure 4
Differentiated keratinocytes show augmented RANTES production
in response to TWEAK and TGF-b1. Human keratinocytes were
cultured in the presence of 0.05 mM Ca2þ (white bars) or 1.2 mM Ca2þ
(black bars) for 2 d and then stimulated with 100 ng per mL of TWEAK
and 0.1, 1.0, or 10 ng per mL of TGF-b1 for 48 h. Then, human RANTES
concentration in the culture supernatants was measured by ELISA.
Data are indicated as the mean  SD of triplicate samples. po0.05,
significantly different from the mean value of the corresponding control
response. Similar results were obtained in three repeated experiments.
Figure5
Phosphorylation of IjB-a in TWEAK-stimulated human keratino-
cytes. Cultured keratinocytes were stimulated with 100 ng per mL of
TWEAK for the indicated time periods (A) or with 100 ng per mL of
TWEAK and/or 10 ng per mL of TGF-b1 for 10 min (B). Then, the cell
lysates were immunoblotted with anti-phosphorylated IkB-a (Ser32)
antibody (upper panels) or anti-IkB antibody (lower panels). Represen-
tative of three repeated experiments with similar results.
Figure 3
TGF-b1 synergizes with TWEAK for RANTES production by human
keratinocytes. Cultured human keratinocytes were stimulated with 100
ng per mL of TWEAK and/or 10 ng per mL of TGF-b1 in the presence or
absence of 5 mg per mL of anti-Fn14 blocking mAb (A) or stimulated
with 100 ng per mL of TWEAK and 0.1, 1.0, or 10 ng per mL of TGF-b1
(B) for 48 h. Then, human RANTES concentration in the culture
supernatants was measured by ELISA. Data are indicated as the
mean  SD of triplicate samples. po0.05, significantly different from
the mean value of the corresponding control response. Similar results
were obtained in three repeated experiments.
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data not shown). We and others have previously shown that
TWEAK induces several cytokines/chemokines; for exam-
ple, IL-8 and MCP-1 from HUVEC (Harada et al, 2002), TNF-a
from certain tumor cell lines (Nakayama et al, 2002), IL-8,
IP-10, and RANTES from human dermal fibroblasts and
synoviocytes (Chicheportiche et al, 2002). Thus, it seemed
that the pattern of cytokines/chemokines induced by
TWEAK varied depending on the cell types.
Because TGF-b has been implicated in the regulation of
inflammation (Wahl, 1992) and is constitutively expressed in
the human epidermis (Quan et al, 2002), we were interested
in examining the effect of TGF-b on TWEAK-induced
RANTES production by human keratinocytes. We found
that TGF-b augmented TWEAK-induced RANTES produc-
tion in human keratinocytes (Figs 3 and 4). Since previous
studies showed that NF-kB activation resulted in upregula-
tion of RANTES (Ebnet et al, 1997; Moriuchi et al, 1997; Ray
et al, 1997), the findings that TWEAK and TGF-b1 showed
an additive increase of phosphorylation of IkB-a (Fig 5B)
might at least in part explain their synergistic action on the
RANTES production. Alternatively, it is possible that TWEAK
and TGF-b1 synergistically upregulate RANTES through
their unique transcriptional factors. Indeed, synergistic
effect of IFN-g and TNF-a for RANTES production was
reported in mouse fibroblasts by Ohmori et al (1997). They
showed that IFN-g and TNF-a synergistically upregulated
RANTES through signal transducer and activator of tran-
scription 1 (STAT1) and NF-kB, which was most likely
mediated by their independent interaction with one or more
components of the basal transcriptional complex.
The differentiated keratinocytes produced significantly
increased amounts of RANTES in response to TGF-b1 or
the combination of TWEAK and TGF-b1 as compared with
undifferentiated keratinocytes (Fig 4). Thus, it appeared that
differentiated keratinocytes were more susceptible to TGF-
b action. Altered responses to TGF-b in undifferentiated
and differentiated keratinocytes were also reported on the
regulation of extracellular matrix gene expression (Vollberg
et al, 1991). The mechanisms underlying these findings
currently remain completely unclear and should be inves-
tigated in future studies.
In summary, we showed a novel biological activity of
TWEAK on human keratinocytes. Because RANTES is a
proinflammatory chemokine, induction of RANTES by TWEAK/
Fn14 interaction in human keratinocytes may be involved in
pathophysiology of certain inflammatory skin disorders.
Materials and Methods
Reagents Recombinant human TWEAK was purchased from
Alexis Biochemicals (California), and recombinant human trans-
forming growth factor-b1 (TGF-b1) and recombinant human
interferon-g (IFN-g) were purchased from R&D Inc (Minnesota).
Anti-human Fn14 monoclonal antibodies (mAb) (ITEM-1 and ITEM-
2) were generated in our laboratory as previously described
(Nakayama et al, 2003). ITEM-2 is a blocking antibody preventing
the interaction between TWEAK and Fn14 (Nakayama et al, 2003).
Keratinocyte culture Normal human keratinocytes from infant
foreskins were cultured in serum-free keratinocyte growth medium,
HuMedia-KG2 (Kurabo Industries, Osaka, Japan), containing
epidermal growth factor (EGF) (0.1 ng per mL), insulin (10 mg per
mL), hydrocortisone (0.5 mg per mL), gentamycin (50 mg per mL),
amphotericin B (50 ng per mL), and bovine brain pituitary extract
(0.4%, vol/vol) at 371C in humidified atmosphere in presence of
5% CO2. The experiments were carried out using third- or fourth-
passage keratinocytes. Induction of keratinocyte differentiation
was achieved by culturing the cells for 48 h in the presence of 1.2
mM Ca2þ in the culture medium as previously described (Stanley
and Yuspa, 1983). Keratinocyte differentiation was confirmed by
morphological change.
Flow cytometric analysis for Fn14 expression Cells (1  106)
were incubated with biotinylated anti-human Fn14 mAb (ITEM-1)
for 1 h at 41C, followed by PE-labeled avidin (BD Pharmingen, San
Diego, California). After washing with PBS, the cells were analyzed
on a FACSCalibur (BD Pharmingen), and the data were analyzed
using the CellQuest program (BD Pharmingen).
Chemokine ELISA The amounts of IL-8, MCP-1, TARC, Eotaxin,
and RANTES in the supernatant of human keratinocytes culture
(1  106 cells/well) were determined using the ELISA kits (R&D)
according to the manufacturer’s instruction.
Western blot Cell lysates of cultured human keratinocytes were
taken after stimulation with recombinant human TWEAK (100 ng
per mL) for the indicated times and were electrophoresed on a
10% sodium dodecylsulfate–polyacrylamide gel and transferred to
Immobilon-P membrane (Millipore, Billerica, Massachusetts). Im-
munoblotting was performed using the phosphoPlus IkB-a (Ser32)
antibody kit (Cell Signaling Technology, Massachusetts) according
to the manufacturer’s instruction.
Data analysis Data are summarized as mean  SD. Statistical
analysis was performed using the unpaired Student’s t test.
po0.05 was considered to be significant.
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